HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EBS

Emergent Biosolutions Inc

Last Close
Mar 11 • 04:00PM ET
5.53
Dollar change
-0.09
Percentage change
-1.60 		%
Healthcare • Drug Manufacturers - Specialty & Generic • USA • NYSE
Peers: MRNA SNY NVAX DVAX INBX OCGN VXRT ADMA XERS HEPA
 | Held by: VTI AVUV VXF XBI PRFZ FNDA DWAS VHT IBB SCHA
Scroll to Statements
Index- P/E- EPS (ttm)-3.72 Insider Own2.43% Shs Outstand54.30M Perf Week-13.46%
Market Cap300.48M Forward P/E6.70 EPS next Y0.83 Insider Trans-2.89% Shs Float53.02M Perf Month-44.70%
Income-190.60M PEG- EPS next Q0.49 Inst Own63.94% Short Float13.38% Perf Quarter-39.56%
Sales1.04B P/S0.29 EPS this Y598.55% Inst Trans9.16% Short Ratio6.03 Perf Half Y-26.46%
Book/sh8.89 P/B0.62 EPS next Y-28.01% ROA-11.80% Short Interest7.09M Perf Year99.64%
Cash/sh1.94 P/C2.85 EPS next 5Y- ROE-33.67% 52W Range1.82 - 15.10 Perf YTD-42.15%
Dividend Est.- P/FCF8.39 EPS past 5Y- ROI-16.49% 52W High-63.38% Beta2.09
Dividend TTM- Quick Ratio1.77 Sales past 5Y2.20% Gross Margin29.21% 52W Low203.83% ATR (14)0.61
Dividend Ex-Date- Current Ratio3.69 EPS Y/Y TTM75.57% Oper. Margin-5.60% RSI (14)21.71 Volatility8.75% 8.83%
Employees900 Debt/Eq1.40 Sales Y/Y TTM-0.62% Profit Margin-18.26% Recom2.00 Target Price14.33
Option/ShortYes / Yes LT Debt/Eq1.39 EPS Q/Q39.45% Payout- Rel Volume1.17 Prev Close5.62
Sales Surprise-21.96% EPS Surprise109.93% Sales Q/Q-29.61% EarningsMar 03 AMC Avg Volume1.18M Price5.53
SMA20-25.36% SMA50-39.25% SMA200-36.61% Trades Volume1,372,080 Change-1.60%
Date Action Analyst Rating Change Price Target Change
Dec-30-24Initiated H.C. Wainwright Buy $15
Aug-22-24Initiated Rodman & Renshaw Buy $16
Mar-07-24Upgrade The Benchmark Company Hold → Buy $5
Nov-20-23Resumed JP Morgan Underweight
Aug-29-23Downgrade The Benchmark Company Buy → Hold
Apr-10-23Upgrade The Benchmark Company Hold → Buy $22
Mar-17-23Downgrade JP Morgan Neutral → Underweight $23 → $9
Nov-10-22Downgrade The Benchmark Company Buy → Hold
Apr-29-22Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-20-22Upgrade The Benchmark Company Hold → Buy $77
Show Previous Ratings
Mar-10-25 09:14AM
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
(GlobeNewswire)
Mar-04-25 06:59AM
Q4 2024 Emergent BioSolutions Inc Earnings Call
(Thomson Reuters StreetEvents) -6.44%
02:45AM
Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript
(Motley Fool)
02:05AM
Emergent BioSolutions Inc (EBS) Q4 2024 Earnings Call Highlights: Strategic Advancements Amid ...
(GuruFocus.com)
Mar-03-25 05:40PM
Emergent Biosolutions (EBS) Q4 Earnings Top Estimates
(Zacks) -8.69%
04:45PM Loading…
04:45PM
Emergent Biosolutions: Q4 Earnings Snapshot
(Associated Press Finance)
04:23PM
Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results
(GlobeNewswire)
Feb-18-25 08:55AM
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
(GlobeNewswire) -14.20%
Feb-07-25 08:06AM
Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
(GlobeNewswire)
Jan-23-25 09:01AM
Emergent seeking to reverse fortunes and become a major overdose treatment player
(Pharmaceutical Technology) +5.61%
Jan-16-25 08:00AM
Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)
(GlobeNewswire)
Jan-14-25 07:30AM
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
(GlobeNewswire)
Jan-13-25 09:27AM
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga (ansuvimab-zykl) Treatment for Ebola
(GlobeNewswire)
Jan-08-25 07:45AM
Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
(GlobeNewswire)
07:30AM
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax (Anthrax Vaccine Adsorbed)
(GlobeNewswire)
05:26PM Loading…
Dec-30-24 05:26PM
Why Emergent BioSolutions Stock Blasted Higher Today
(Motley Fool) +11.85%
Dec-16-24 08:00AM
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted)
(GlobeNewswire)
Dec-03-24 06:47PM
Why Emergent BioSciences Stock Plummeted Today
(Motley Fool) -5.59%
Nov-08-24 10:04AM
Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
(GuruFocus.com) +7.00%
Nov-07-24 02:06PM
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
(Benzinga) +19.57%
01:15AM
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript
(Motley Fool)
Nov-06-24 06:20PM
Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates
(Zacks)
05:17PM
Emergent Biosolutions: Q3 Earnings Snapshot
(Associated Press Finance)
04:49PM
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
(GlobeNewswire)
04:05PM
Emergent BioSolutions Reports Third Quarter 2024 Financial Results
(GlobeNewswire)
Nov-04-24 07:30AM
Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
(GlobeNewswire)
Oct-23-24 07:30AM
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024
(GlobeNewswire) -5.20%
Oct-11-24 12:33PM
Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024
(Insider Monkey)
Oct-09-24 05:09PM
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...
(GuruFocus.com) -5.38%
11:09AM
Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says
(Pharmaceutical Technology)
05:32PM Loading…
Oct-08-24 05:32PM
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN Nasal Spray to Help Combat the Opioid Epidemic
(GlobeNewswire)
Oct-02-24 07:30AM
Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility
(GlobeNewswire) +8.50%
Sep-26-24 08:05AM
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA (brincidofovir) to Support National Preparedness Efforts
(GlobeNewswire) +22.56%
Sep-25-24 07:07AM
Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
(GlobeNewswire)
Sep-13-24 06:45AM
Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation
(GlobeNewswire)
Sep-12-24 08:30AM
Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga Treatment for Ebola
(GlobeNewswire)
01:27AM
BlackRock Inc. Reduces Stake in Emergent BioSolutions Inc.
(GuruFocus.com)
Sep-04-24 05:51PM
OHA is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing
(GlobeNewswire)
08:00AM
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
(GlobeNewswire)
Sep-03-24 07:08AM
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
(GlobeNewswire) -11.07%
Aug-30-24 09:55AM
Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine
(Barrons.com) -6.73%
08:33AM
This Biotech Stock Surges As WHO Health Emergency Stirs FDA Approval
(Investor's Business Daily)
08:33AM
Emergent BioSolutions Stock Storms Higher After The FDA Signs Off On Mpox Vaccine
(Investor's Business Daily)
08:16AM
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
(GlobeNewswire)
04:32AM
Emergent gains FDA approval for ACAM2000 vaccine for Mpox
(Pharmaceutical Technology)
Aug-29-24 06:53PM
Emergent BioSolutions' ACAM2000 , (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions
(GlobeNewswire)
Aug-21-24 11:14AM
Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals
(Pharmaceutical Technology) +8.82%
Aug-20-24 12:03PM
Emergent joins mpox fight with 50,000 vaccine dose donation to Africa
(Pharmaceutical Technology) -20.33%
11:30AM
Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals
(GlobeNewswire)
Aug-19-24 05:16PM
WHO declares mpox a public health emergency as variant emerges
(Yahoo Finance Video) +12.66%
05:10PM
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
(GlobeNewswire)
Aug-16-24 04:14PM
Emergent Leads Mpox-Tied Stock Gains as Investors Await Approval
(Bloomberg) +24.02%
12:51PM
Why Emergent BioSolutions Stock Is Skyrocketing Today
(Motley Fool)
09:52AM
Mpox Vaccine Makers Stock Soars After Fresh WHO Warning
(Barrons.com)
Aug-07-24 02:45AM
Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript
(Motley Fool) -41.99%
Aug-06-24 05:14PM
Emergent Biosolutions: Q2 Earnings Snapshot
(Associated Press Finance)
05:01PM
Emergent BioSolutions Reports Second Quarter 2024 Financial Results
(GlobeNewswire)
08:00AM
Emergent BioSolutions Expands NARCAN Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
(GlobeNewswire)
Jul-31-24 09:06AM
SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL (Reactive Skin Decontamination Lotion) kit for $75 million
(GlobeNewswire) +7.08%
08:53AM
Emergent BioSolutions Completes Sale of RSDL (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million
(GlobeNewswire)
Jul-25-24 01:20PM
The stock markets cruel summer is about to get much worse
(MarketWatch)
Jul-24-24 07:30AM
Emergent BioSolutions Launches Opioid Emergency Preparedness 'Lay, Spray, Stay' Public Education Campaign Starring Pro Football Hall of Famer Emmitt Smith
(GlobeNewswire) +10.57%
Jul-23-24 08:27AM
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
(GlobeNewswire) +8.99%
Jul-22-24 08:00AM
Emergent BioSolutions Announces Shelf-Life Extension for NARCAN Nasal Spray in Canada
(GlobeNewswire)
Jul-09-24 07:30AM
Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan
(GlobeNewswire) +7.26%
Jul-03-24 10:13AM
Emergent scores US medical countermeasure contracts worth over $250m
(Pharmaceutical Technology)
Jul-02-24 09:43AM
Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
(GlobeNewswire) +6.09%
08:13AM
Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
(GlobeNewswire)
Jun-24-24 06:35AM
7 Top Stocks Under $10: June 2024 Edition
(InvestorPlace)
Jun-21-24 06:53AM
Emergent to sell US sterile manufacturing facility to Bora
(Pharmaceutical Technology)
Jun-20-24 07:00AM
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million
(GlobeNewswire) +6.77%
Jun-06-24 09:02AM
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day
(GlobeNewswire) -6.15%
May-21-24 07:00AM
7 Stocks to Buy Immediately Following Strong Earnings
(InvestorPlace) -10.69%
May-16-24 04:09PM
Vice Stock Vanguards: 3 Sin Stocks Delivering Heavenly Returns
(InvestorPlace) -7.71% +5.31%
May-10-24 07:17AM
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
(GlobeNewswire)
May-02-24 01:48PM
Top Midday Gainers
(MT Newswires) +70.98%
12:33PM
Q1 2024 Emergent BioSolutions Inc Earnings Call
(Thomson Reuters StreetEvents)
12:10PM
MercadoLibre Stock Split: Will MELI Investors See Wishes Come True Today?
(InvestorPlace)
11:27AM
JPMorgan Just Raised Its Price Target on Carvana (CVNA) Stock
(InvestorPlace)
11:13AM
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts
(InvestorPlace)
10:38AM
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
(Insider Monkey)
08:00AM
Top Premarket Gainers
(MT Newswires)
07:58AM
Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?
(InvestorPlace)
07:37AM
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
(InvestorPlace)
03:54AM
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
(GuruFocus.com)
12:42AM
PRESS DIGEST- Wall Street Journal - May 2
(Reuters)
May-01-24 11:45PM
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
(Motley Fool)
10:56PM
EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024
(InvestorPlace)
06:15PM
Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
(GuruFocus.com)
05:53PM
Emergent Biosolutions: Q1 Earnings Snapshot
(Associated Press Finance)
05:52PM
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
(The Wall Street Journal)
04:57PM
Emergent BioSolutions Reports First Quarter 2024 Financial Results
(GlobeNewswire)
04:34PM
UPDATE 2-Emergent BioSolutions to lay off about 300 employees
(Reuters)
04:21PM
Emergent BioSolutions to cut 300 jobs
(Reuters)
04:10PM
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
(GlobeNewswire)
11:03AM
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
(GlobeNewswire)
Apr-30-24 05:26PM
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
(GlobeNewswire)
Apr-22-24 08:05AM
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
(GlobeNewswire) +5.88%
Apr-01-24 08:00AM
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
(GlobeNewswire) -9.09%
Mar-28-24 08:15AM
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
(GlobeNewswire)
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeGolyer Donald WDirectorNov 12 '24Sale10.9125,000272,750111,100Nov 14 04:18 PM
White Marvin LDirectorNov 11 '24Sale11.9714,287171,01554,092Nov 13 04:04 PM
DeGolyer Donald WDirectorNov 12 '24Proposed Sale11.7725,000294,250Nov 12 05:16 PM
White Marvin LDirectorNov 11 '24Proposed Sale11.7714,287168,158Nov 12 10:34 AM
Zoon Kathryn CDirectorJun 04 '24Sale6.1110,00061,10054,482Jun 06 04:16 PM
Zoon Kathryn CDirectorMay 29 '24Sale4.611,8308,43664,482May 31 03:02 PM
Zoon Kathryn CDirectorMay 21 '24Sale5.781,0896,29448,882May 23 05:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.